Vringo (VRNG) has been the fortunate recipient of some very interesting news over the past few days. First the judge ruled that Google's workaround is not really a workaround and that they still owe Vringo royalties. The second and possibly bigger ruling came when the judge even enhanced the royalty rate to 6.5% of the royalty base of Google's US revenues. This could be an interesting stock to watch and expect a Seeking Alpha article out later on Vringo's recent developments.
Stock Ideas for Average investors is about people finding out ideas for stocks that they would potentially invest in. This blog is focused more on the biotechnology side of the industry, however other stock suggestions are more than welcome.
Popular Posts
-
As Orexigen Pharmaceuticals ( NASDAQ: OREX ) once again prepares to face the FDA over its weight loss drug Contrave, we must take a...
-
With Anthera Pharmaceuticals (ANTH) trading at near a 52 week low, investors are left wondering whether or not this is the start of a new ...
-
Titan Pharmaceuticals (NASDAQOTC: TTNP) announced on Wednesday an amendment to its agreement with Braeburn Pharmaceuticals . This amendme...
Friday, January 31, 2014
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment